Search result for Bioscience
CATALENT ACQUIRES A SUBSIDIARY OF PROMETHERA BIOSCIENCES
HIGHLIGHTS
- Catalent has acquired a subsidiary of Promethera Biosciences.
- Catalent is growing its operations in Europe.
- This is the third acquisition by Catalent in Belgium.
The Somerset-based Catalent is growing in Europe....
CHINA DEVELOPED mRNA VACCINE LIKELY TO START TRIALS NEXT MONTH
Highlights –
- China developed mRNA vaccine likely to start trials next month.
- The vaccine candidate ARCoV is said to be the furthest along the clinical trial process at present.
- The vaccine may get overseas approval to conduct Phase II...
SOFTBANK TO INVEST $900 MILLION IN US-BASED PACIFIC BIOSCIENCES OF CALIFORNIA
Highlights
• SoftBank Group has decided to invest $900 million in a US developer of equipment for genetic analysis
• This investment comes as billionaire Masayoshi Son’s SoftBank Group is looking to diversify its portfolio and mainly US listed companies
...S. KOREA DRUG SAFETY AGENCY APPROVES ASTRAZENECA’S COVID-19 VACCINE
Highlights –
- S. Korea's drug safety agency approves AstraZeneca’s COVID-19 vaccine.
- AstraZeneca’s vaccine has been approved to be used for people aged 65 and older.
- AstraZeneca will start delivering the first batch of ...
SK BIOSCIENCE LOOKING AT AN IPO MONEYSPINNER WITH ASTRAZENECA COVID-19 VACCINE DEAL
- Ever since a deal was reached in July for SK Bioscience to manufacture AstraZeneca's COVID-19 vaccine, the SK subsidiary has already succeeded in producing the vaccine at its Andong L HOUSE vaccine center.
- While some vials of the vaccine produced have already been exported,...
KOREA ENTERS PACT WITH ASTRAZENECA TO PROCURE COVID-19 VACCINE
- The government has signed a pact with AstraZeneca to procure 25 million doses of its COVID-19 vaccine.
- It says that SK Bioscience would carry the onus of manufacture of the vaccine, known as AZD1222, for domestic distribution.
According to finite...
BILL GATES BACKED SK BIOSCIENCE CAN PRODUCE 200 MILLION
Highlights:
• Bill Gates has funded SK BioScience a covid19 vaccine development worth $3.6 million in
• SK Bioscience is also developing its candidates for COVID vaccines
Bill Gates foundation has now donated ...
BILL GATES IN A TETE-A-TETE WITH PRESIDENT MOON
- Microsoft Chairman Bill Gates had a word with President Moon of Korea and in his conversation.
- He lauded President Moon for the efforts taken in the direction for developing a vaccine to combat the COVID-19 pandemic.
He was unduly impressed with the response o...
BILL GATES: SOUTH KOREAN FIRM COULD MAKE 200 MILLION COVID-19 VACCINE KITS BY JUNE
Highlights:
- SK Bioscience, the South Korean pharmaceutical company capable of producing 200 million coronavirus vaccine kits by June 2021.
- The SK Bioscience has received $3.6 million in May by the US Billionaire’s foundation to accelerate the de...
JW Bioscience to market the biochemical analysis equipment for JEOL
JW Bioscience, a subsidiary of JW Holdings, said it would market the biochemical analysis equipment for JEOL exclusively in Korea.
The marketing agreement at JW Tower in Seocho-gu, Seoul, was signed on Monday by JW Bioscience CEO Hahm Eun-kyung (right) and JEOL executive responsible for...
Nightstar Therapeutics along with Genocea Biosciences is a critical Contrast
Nightstar Therapeutics and Genocea Biosciences are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation. 39....
NutraLife Biosciences (NLBS) Announces New Phytocannabinoid Rich (PCR Pure) Water Enhancing Product Line
NutraLife Biosciences, Inc. (OTCQB: NLBS) to launch a new line of Phytocannabinoid rich (PCR) water enhancing drops under its new in-house brand PCR Pure. NutraLife’s new CBD water enhancers will initially be available in four flavors: strawberry, grape, coconut and watermelon. Each 2 oz. bottle wi...
NutraLife Biosciences Inc. Reports 2018 Year End Financial Results
NutraLife Biosciences Inc., (OTCQB: NLBS), a developer, manufacturer and distributor of nutraceutical and CBD products, recently announced the its Form 10-k had been filled and the financial calculations were compiled and ended on December 31st, 2018. In Form 10-K for the year ended De...
Proscere Bioscience Division of Simlatus to close an export CBD deal in Europe — Expects $225M according to the markets
The Simlatus Corporation reveals that their CBD division of Proscere Bioscience has eventually gotten the date of until 31st March 2019 along with the Swiss-based CBD Company. Proscere Bioscience is known for manufacturing and distributing cold water commercially as a part of the CBD s...